AstraZeneca 的s $80bn in 年一回の 歳入s by 2030
- Britain's largest 製薬の 商売／仕事 達成するd $45.8bn in turnover last year
- AstraZeneca now wants to 上げる 年次の turnover by an 付加 75% by 2030
AstraZeneca is 的ing $80billion in 年次の 歳入s by 2030, supported by the 開始する，打ち上げる of 20 new 薬／医学s.
Britain's largest 製薬の 商売／仕事 達成するd $45.8billion in turnover last year, in line with a goal 始める，決める ten years ago, 大部分は thanks to rising 需要・要求する for its oncology and 糖尿病 治療s.
It now wants to 上げる 年次の turnover by an 付加 75 per cent by the start of the next １０年間 through continued growth in sales of its oncology, biopharmaceuticals and rare 病気 大臣の地位.
Goal reached: AstraZeneca 達成するd $45.8billion in turnover last year, in line with a goal 始める，決める ten years ago, 大部分は thanks to rising 需要・要求する for its oncology and 糖尿病 治療s
The London-lis ted company also 推定する／予想するs to create 20 more 麻薬s, some 潜在的に 生成するing over $5billion in 歳入 per year.
と一緒に this, AstraZeneca ーするつもりであるs to 解除する its 核心 operating 利ざや to a '中央の-30s 百分率' within two years by 支えるing 生産性, while still 支持するing its 研究 and 開発 かかわり合いs.
By the same date, the 会社／堅い hopes to be 炭素-無 in its 放出／発行s from 生産／産物 and electricity 購入（する）d for its use.
Pascal Soriot, 長，指導者 (n)役員／(a)執行力のある of AstraZeneca, said the group was entering 'a new 時代 of growth', 力／強力にするd by an 'innovative pipeline, which has the 可能性のある to transform millions of lives'.
He 追加するd: 'The breadth of our 大臣の地位, together with continued 投資 in 革新, supports 支えるd growth 井戸／弁護士席 past the end of the １０年間.'
Under Soriot's leadership, AstraZeneca has rebuilt its pipeline of new 麻薬s and overtaken oil 巨大（な） 爆撃する to become the largest company by market capitalisation on the London 在庫／株 交流.?
On Monday, AstraZeneca 明かすd 計画（する）s to build a $1.5billion 製造業の 施設 in Singapore 充てるd to making antibody-麻薬 conjugates (ADCs).
ADCs are 麻薬s that use antibodies to 配達する 癌-殺人，大当り スパイ／執行官s 直接／まっすぐに to 癌 独房s while sparing healthy 独房s and having より小数の major 味方する 影響s than 伝統的な chemotherapy.
AstraZeneca said the ーするつもりであるd 場所／位置 in Singapore will start design and construction later this year and be 'operationally ready' by 2029.
The 告示 （機の）カム about a fortnight after the 商売／仕事 withdrew its Covid-19 ワクチン from 全世界の 循環／発行部数 まっただ中に 関心s that it 原因（となる）d a rare and dangerous 味方する 影響.
The ワクチン is 広範囲にわたって credited with saving millions of lives since the pandemic began, and AstraZeneca said the 決定／判定勝ち（する） to take it off the market was 商業の.
AstraZeneca 株 were 0.7 per cent higher at £121.76 on Tuesday morning and have 二塁打d over the past five years.
